Related Experiment Video
Updated: Jul 25, 2026
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Increased left ventricular mass in obese adolescents
P Friberg1, A Allansdotter-Johnsson, A Ambring
1Department of Clinical Physiology, Sahlgrenska Academy at Göteborg University, Sahlgrenska University Hospital, Göteborg, Sweden. fribergp@mednet.gu.se
European Heart Journal
|June 3, 2004
Summary
Obese adolescents show increased left ventricular mass (LVM) compared to lean peers, as measured by cardiac MRI. This finding highlights the cardiovascular risks associated with adolescent obesity.
Area of Science:
- Cardiology
- Pediatrics
- Obesity Research
Background:
- Obesity in adolescents is linked to cardiovascular changes.
- Previous studies using echocardiography suggested increased left ventricular mass (LVM) in obese youth.
Purpose of the Study:
- To quantify the increase in LVM in obese adolescents compared to lean controls.
- To explore correlations between LVM and cardiovascular risk factors using cardiac magnetic resonance imaging (CMR).
Main Methods:
- Cardiac MRI was used to assess LVM in 19 obese and 20 lean adolescents.
- Measurements included blood pressure, insulin, triglycerides, and cholesterol levels.
Main Results:
- Obese adolescents had 16% greater LVM adjusted for body height (p=0.0042).
- Obese subjects exhibited higher systolic blood pressure (p=0.0077), triglyceride, and insulin levels.
- Lower HDL-cholesterol levels were observed in the obese group.
Conclusions:
- Obese adolescents present with significantly higher LVM than their lean counterparts.
- Increased LVM in obese youth correlates with body mass index and systolic blood pressure.
- These results reinforce the established cardiovascular risk profile associated with adolescent obesity.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...